Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Interleukin Genetics to develop genetic test for obesity:

This article was originally published in Clinica

Executive Summary

Interleukin Genetics is to develop a genetic test to guide weight loss in obese individuals. The Waltham, Massachusetts company will use its perilipin genetic technology, in-licensed from Tufts University, to assess patients' variations in the perilipin gene. Genetic variations of this type are associated with differences in fat metabolism, body weight, and rate of weight loss on calorie restricted diets. Interleukin's proprietary genetic test will assist physicians and medically-supervised weight loss clinics in guiding obese patients to more effective weight loss. One in three US individuals is now classified as obese, and 127 million are overweight.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049284

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel